Aavas Financiers Provisional ICRAAAA(SO) Rating Assigned to Series A1 PTCs Backed by Home Loans
Aavas Financiers Limited announced the assignment of a Provisional [ICRA]AAA(SO) rating by ICRA Limited for the Series A1 Pass-Through…
Rashtriya Chemicals & Fertilizers Explanation Provided for Delay in Income Tax Demand Disclosure
Rashtriya Chemicals and Fertilizers Limited (RCF) has issued a clarification regarding a delayed filing concerning a demand notice from the…
Alivus Life Sciences Receipt of Income Tax Assessment Order for FY 2022-23
Alivus Life Sciences Limited has disclosed the receipt of an assessment order from the Income Tax Department for Assessment Year 2023-24…
ALKEM Laboratories Launches Semaglutide Injection in India Starting at INR 450 Weekly
Alkem Laboratories has announced the launch of Semaglutide injection in India for type-2 diabetes and chronic weight management. The weekly…
Sai Life Sciences Limited Disclosure Regarding Income Tax Order for Non-Deduction of TDS
Sai Life Sciences Limited has disclosed receipt of an Order dated March 18, 2026, from the Deputy Commissioner of Income Tax (International…
Jubilant FoodWorks Executive Vice President Gaurav Pande Resigns
Jubilant FoodWorks Limited announced the resignation of Mr. Gaurav Pande, Executive Vice President and Head of Corporate Strategy and Senior…
Sun Pharmaceutical Industries Launches Semaglutide Injectable Under Noveltreat and Sematrinity Brands in India
Sun Pharma has announced the launch of its semaglutide injection in India under two new brand names: Noveltreat (for weight management) and…
Zydus Lifesciences Launches Semaglutide Injection with Innovative Reusable Multi-Dose Pen in India
Zydus Lifesciences has launched its Semaglutide Injection in India under the brand names SEMAGLYN, MASHEMA, and ALTERME, following patent…
Delhivery Limited NCLT Sanctions Merger of Spoton Logistics Subsidiaries with Transferee Company
The National Company Law Tribunal (NCLT), New Delhi, has officially approved the Scheme of Amalgamation involving the merger of Spoton…
Dr. Reddy’s Laboratories Launches India’s First DCGI-Approved Semaglutide Injection ‘Obeda®’ for Type 2 Diabetes
Dr. Reddy’s Laboratories has announced the launch of its injectable semaglutide under the brand name Obeda®, making it the first Indian…